These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

803 related articles for article (PubMed ID: 9250266)

  • 21. Discontinuation of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus type I-infected patients: the changes in opportunistic prophylaxis study.
    Mussini C; Pezzotti P; Govoni A; Borghi V; Antinori A; d'Arminio Monforte A; De Luca A; Mongiardo N; Cerri MC; Chiodo F; Concia E; Bonazzi L; Moroni M; Ortona L; Esposito R; Cossarizza A; De Rienzo B
    J Infect Dis; 2000 May; 181(5):1635-42. PubMed ID: 10823763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV-infection.
    Briel M; Bucher HC; Boscacci R; Furrer H
    Cochrane Database Syst Rev; 2006 Jul; (3):CD006150. PubMed ID: 16856118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dapsone-pyrimethamine compared with aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection. The PRIO Study Group.
    Girard PM; Landman R; Gaudebout C; Olivares R; Saimot AG; Jelazko P; Gaudebout C; Certain A; Boué F; Bouvet E
    N Engl J Med; 1993 May; 328(21):1514-20. PubMed ID: 8479488
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of three regimens for treatment of mild to moderate Pneumocystis carinii pneumonia in patients with AIDS. A double-blind, randomized, trial of oral trimethoprim-sulfamethoxazole, dapsone-trimethoprim, and clindamycin-primaquine. ACTG 108 Study Group.
    Safrin S; Finkelstein DM; Feinberg J; Frame P; Simpson G; Wu A; Cheung T; Soeiro R; Hojczyk P; Black JR
    Ann Intern Med; 1996 May; 124(9):792-802. PubMed ID: 8610948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discontinuing prophylaxis against Pneumocystis carinii pneumonia.
    Le Moal G; Breux JP; Roblot F
    N Engl J Med; 2001 May; 344(21):1639-41. PubMed ID: 11374363
    [No Abstract]   [Full Text] [Related]  

  • 26. Predictors for failure of Pneumocystis carinii pneumonia prophylaxis. Multicenter AIDS Cohort Study.
    Saah AJ; Hoover DR; Peng Y; Phair JP; Visscher B; Kingsley LA; Schrager LK
    JAMA; 1995 Apr; 273(15):1197-202. PubMed ID: 7707627
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of trimethoprim-sulfamethoxazole, dapsone, and pentamidine in the prophylaxis of Pneumocystis carinii pneumonia.
    Warnock AC; Rimland D
    Pharmacotherapy; 1996; 16(6):1030-8. PubMed ID: 8947975
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 1995 revised guidelines for prophylaxis against Pneumocystis carinii pneumonia for children infected with or perinatally exposed to human immunodeficiency virus. National Pediatric and Family HIV Resource Center and National Center for Infectious Diseases, Centers for Disease Control and Prevention.
    MMWR Recomm Rep; 1995 Apr; 44(RR-4):1-11. PubMed ID: 7565543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Withdrawal of Pneumocystis carinii pneumonia prophylaxis in patients receiving efficacious combined antiretroviral treatment. Study of 85 cases].
    García Vázquez E; de Górgolas Hernández M; García Delgado R; Fernández Guerrero ML
    Med Clin (Barc); 1999 Jun; 113(3):89-90. PubMed ID: 10464742
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of Pneumocystis jirovecii pneumonia in HIV-infected patients: a review.
    Huang YS; Yang JJ; Lee NY; Chen GJ; Ko WC; Sun HY; Hung CC
    Expert Rev Anti Infect Ther; 2017 Sep; 15(9):873-892. PubMed ID: 28782390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reasons for failure of prophylaxis for Pneumocystis carinii pneumonia.
    Edge MD; Rimland D
    AIDS; 1999 May; 13(8):991-2. PubMed ID: 10371182
    [No Abstract]   [Full Text] [Related]  

  • 32. Pneumocystis carinii pneumonia after cessation of secondary prophylaxis in a patient on highly active antiretroviral therapy with a CD4 cell count greater than 200/mm3.
    Lim L ; Street AC; Lewin SR
    AIDS; 2001 Sep; 15(14):1912-3. PubMed ID: 11579267
    [No Abstract]   [Full Text] [Related]  

  • 33. Discontinuation of secondary prophylaxis for Pneumocystis pneumonia in human immunodeficiency virus-infected children treated with highly active antiretroviral therapy.
    Esposito S; Bojanin J; Porta A; Cesati L; Gualtieri L; Principi N
    Pediatr Infect Dis J; 2005 Dec; 24(12):1117-20. PubMed ID: 16371882
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Toxicity and efficacy of daily vs. weekly dapsone for prevention of Pneumocystis carinii pneumonia in children infected with human immunodeficiency virus. ACTG 179 Study Team. AIDS Clinical Trials Group.
    McIntosh K; Cooper E; Xu J; Mirochnick M; Lindsey J; Jacobus D; Mofenson L; Yogev R; Spector SA; Sullivan JL; Sacks H; Kovacs A; Nachman S; Sleasman J; Bonagura V; McNamara J
    Pediatr Infect Dis J; 1999 May; 18(5):432-9. PubMed ID: 10353516
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A case of pneumocystis pneumonia after cessation of secondary prophylaxis.
    Quah SP; McBride M
    Int J STD AIDS; 2001 Feb; 12(2):126-7. PubMed ID: 11236102
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pneumocystis carinii pneumonia prophylaxis during pregnancy.
    Connelly RT; Lourwood DL
    Pharmacotherapy; 1994; 14(4):424-9. PubMed ID: 7937279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of dapsone in the prevention and treatment of Pneumocystis carinii pneumonia: a review.
    Hughes WT
    Clin Infect Dis; 1998 Jul; 27(1):191-204. PubMed ID: 9675476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Validating literature-based models with direct clinical trial results: the cost-effectiveness of secondary prophylaxis for PCP in AIDS patients.
    Freedberg KA; Hardy WD; Holzman RS; Tosteson AN; Craven DE
    Med Decis Making; 1996; 16(1):29-35. PubMed ID: 8717596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prophylaxis of Pneumocystis carinii pneumonia: too much of a good thing?
    Miller RF
    Thorax; 2000 Aug; 55 Suppl 1(Suppl 1):S15-22. PubMed ID: 10943633
    [No Abstract]   [Full Text] [Related]  

  • 40. Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy. Swiss HIV Cohort Study.
    Furrer H; Egger M; Opravil M; Bernasconi E; Hirschel B; Battegay M; Telenti A; Vernazza PL; Rickenbach M; Flepp M; Malinverni R
    N Engl J Med; 1999 Apr; 340(17):1301-6. PubMed ID: 10219064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.